- Trials with a EudraCT protocol (79)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
79 result(s) found for: Ileum.
Displaying page 1 of 4.
EudraCT Number: 2022-001710-19 | Sponsor Protocol Number: LUMINALSONAZOID001 | Start Date*: 2022-11-01 |
Sponsor Name:Medical department, Haukeland University Hospital | ||
Full Title: Sonographic diagnostics with oral contrast for Crohns. A novel method for detecting Crohns disease using sonographic intraluminal contrast. | ||
Medical condition: Crohns disease in the terminal ileum | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010163-16 | Sponsor Protocol Number: 08/0285 | Start Date*: 2009-06-05 | ||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||
Full Title: Bile salt manipulation as a novel treatment for Crohn’s disease: a single centre open label pilot study of atorvastatin and colesevalam in patients with active ileal Crohn’s disease | ||||||||||||||||||
Medical condition: Active Crohn's disease affecting the ileum | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003179-23 | Sponsor Protocol Number: GS-US-419-4015 | Start Date*: 2017-04-13 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn’s Disease (SBCD) | |||||||||||||
Medical condition: Small Bowel Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) CZ (Completed) ES (Completed) PL (Completed) HU (Completed) FR (Completed) AT (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002319-26 | Sponsor Protocol Number: D8830C00002 | Start Date*: 2005-12-20 |
Sponsor Name:AstraZeneca AB | ||
Full Title: Efficacy and safety of AZD9056 200 mg once daily versus placebo in adult patients with active Crohn’s disease – A randomized, double-blind, four week, parallel-group, multicentre, phase II study | ||
Medical condition: Crohn's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) AT (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000473-39 | Sponsor Protocol Number: CIR-ILI-2014 | Start Date*: 2015-01-19 | |||||||||||
Sponsor Name:Fundacio Parc Taulí | |||||||||||||
Full Title: Randomized and prospective clinical trial about the therapeutic use of diatrizoic acid (Gastrografin®) in postoperative ileus. | |||||||||||||
Medical condition: Postoperative paralytic Ileus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002939-15 | Sponsor Protocol Number: V56502 | Start Date*: 2017-01-24 | |||||||||||
Sponsor Name:VHsquared Ltd | |||||||||||||
Full Title: A Phase 2 study to investigate the efficacy, safety, and tolerability of six weeks treatment with V565 in subjects with active Crohn’s disease. | |||||||||||||
Medical condition: Active Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) AT (Completed) HU (Completed) SK (Completed) NL (Completed) NO (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002209-12 | Sponsor Protocol Number: ABR59689 | Start Date*: 2017-06-21 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Erasmus MC-Sophia Children's Hospital | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Less opioids after major abdominal surgery in young infants using wound catheter infusion with local anesthetics: a randomized controlled trial. | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Children < 1 year of age undergoing major open abdominal surgery. | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-002751-19 | Sponsor Protocol Number: 82160 | Start Date*: 2023-04-11 |
Sponsor Name:Amsterdam UMC | ||
Full Title: FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients | ||
Medical condition: Inflammatory Bowel Diseases | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004269-14 | Sponsor Protocol Number: BIRD2018001 | Start Date*: 2019-11-08 |
Sponsor Name:Belgian IBD research and development | ||
Full Title: Loss of RESponse to Ustekinumab treated by dose Escalation | ||
Medical condition: Crohn’s disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003499-18 | Sponsor Protocol Number: PI2022_843_0111 | Start Date*: 2023-03-22 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Is there a concordance between the Cellvizio with an intravenous injection of fluorescein and the pathology to determine the microscopic inflammation at the ileal resection margins in Crohn’s ileal... | ||
Medical condition: Crohn’s ileal disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001678-17 | Sponsor Protocol Number: FFP104-002 | Start Date*: 2015-12-01 |
Sponsor Name:Fast Forward Pharmaceuticals, B.V. | ||
Full Title: A Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects with Moderate to Severely Active Croh... | ||
Medical condition: Moderate to Severely Active Crohn’s disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000481-58 | Sponsor Protocol Number: MLN0002SC-3031 | Start Date*: 2016-01-22 | |||||||||||
Sponsor Name:Takeda Development Centre Europe, Ltd. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Cr... | |||||||||||||
Medical condition: Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) CZ (Completed) NL (Completed) BG (Completed) GB (Completed) DE (Completed) BE (Completed) SE (Completed) DK (Completed) LT (Completed) HU (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000189-19 | Sponsor Protocol Number: DSC/06/2357/23 | Start Date*: 2007-08-06 | |||||||||||
Sponsor Name:Italfarmaco S.p.A. | |||||||||||||
Full Title: Multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of ITF2357 on mucosal healing in patients with moderate-to-severe active Crohn’s Disease | |||||||||||||
Medical condition: Moderate-to-severe active Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) BE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004331-39 | Sponsor Protocol Number: INDOOR | Start Date*: 2015-01-02 | |||||||||||
Sponsor Name:Fundació Vall Hebron Institut de Recerca | |||||||||||||
Full Title: HIV Reservoir Dynamics After Switching To Dolutegravir in Patients on a PI/r Based Regimen. A Phase IV Open Randomized Trial | |||||||||||||
Medical condition: HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001212-30 | Sponsor Protocol Number: GW/MB/42964 | Start Date*: 2013-07-04 |
Sponsor Name: | ||
Full Title: Modulation of immune function by parenteral fish oil in patients with Crohn’s disease and high inherent Tumor Necrosis Factor-alfa production, a randomized, single blinded, cross-over study | ||
Medical condition: Crohn's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005226-29 | Sponsor Protocol Number: IBD-0337 | Start Date*: Information not available in EudraCT |
Sponsor Name:Wolfson Medical Center | ||
Full Title: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease | ||
Medical condition: Crohn's disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) BE (Completed) PL (Completed) PT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004132-20 | Sponsor Protocol Number: D9423C00001 | Start Date*: 2016-07-28 | |||||||||||
Sponsor Name:AstraZeneca K.K. | |||||||||||||
Full Title: A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease in Japan | |||||||||||||
Medical condition: Active Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002275-40 | Sponsor Protocol Number: 2006-002275-40 | Start Date*: 2007-01-24 |
Sponsor Name:Uppsala University Hospital, Dept. of Medical Sciences | ||
Full Title: Prospective study of patients treated with pegylated interferon-alpha 2b (PegIntron) for metastasizing ileal/coecal carcinoids | ||
Medical condition: Metastasizing ileal/coecal carcinoids (WHO ICD-10 code: C17.9) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002369-17 | Sponsor Protocol Number: 2021-01 | Start Date*: 2021-07-22 |
Sponsor Name:GETAID | ||
Full Title: Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial, the POMEROL trial. | ||
Medical condition: Crohn's disease patients having an i2 endoscopic postoperative recurrence 6-12 months after ileocolonic anastomosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001925-18 | Sponsor Protocol Number: GED-0301-CD-002 | Start Date*: 2016-02-24 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of mongersen (GED-0301) for the treatment of subjects with active Crohn’s disease. | |||||||||||||
Medical condition: Active Crohn's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) SE (Completed) SK (Completed) LV (Prematurely Ended) EE (Prematurely Ended) DE (Prematurely Ended) PT (Prematurely Ended) HU (Completed) CZ (Prematurely Ended) AT (Prematurely Ended) ES (Prematurely Ended) DK (Prematurely Ended) BE (Completed) NO (Completed) BG (Prematurely Ended) GR (Completed) HR (Prematurely Ended) FI (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
